Status:
RECRUITING
COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor
Lead Sponsor:
Università Vita-Salute San Raffaele
Conditions:
Coronavirus Infections
Eligibility:
All Genders
18+ years
Brief Summary
Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to ...
Eligibility Criteria
Inclusion
- Patients admitted to hospital with biological samples positive for SARS-CoV-2
- Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease
- Patients discharged from emergency department with biological samples positive for SARS-CoV-2
Exclusion
- None
Key Trial Info
Start Date :
March 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 19 2026
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT04318366
Start Date
March 19 2020
End Date
March 19 2026
Last Update
August 6 2025
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Autoimmunity and Vascular Inflammation Unit, Division of Regenerative Medicine, Stem Cells and Gene Therapy - IRCCS San Raffaele Scientific Institute
Milan, Lombardy, Italy, 2012
2
AIDS Immunopathogenesis Unit - IRCCS San Raffaele Scientific Institute
Milan, Lombardy, Italy, 20132
3
Department of Infection Diseases - IRCCS San Raffaele Scientific Institute -
Milan, Lombardy, Italy, 20132
4
Department of Internal Medicine - IRCCS San Raffaele Scientific Institute
Milan, Lombardy, Italy, 20132